EMERGING ISRAELI BIOPHARMA FLIES FLAG FOR EX-BMS CANCER THERAPY by Phil Taylor | Apr 10, 2018 9:57am | FierceBiotech Israeli biotech Ayala Pharmaceuticals, founded last year as a development vehicle for two…
10 Apr 2018 | MEDTECH NEWS by Catherine Longworth Israel has set its sights on becoming a global leader in digital health, boosted by the government's new five-year plan to invest…
Dr. Barak Azmon, an ophthalmologist and serial entrepreneur, is convinced Israel can become a 'meaningful player' in vision-related developments By SHOSHANNA SOLOMON| April 2018, 12:31 pm | Times of Israel Dr.…
MIXiii-Biomed 2018 – Registration and program online MIXiii-Biomed 2018 is fast approaching. This prestigious conference and exhibition is once again ready to launch start-ups into the international arena and to…
Israel's 17th national life science and technology week to be held on May 15-17, 2018 at the David InterContinental Hotel in Tel Aviv NEWS PROVIDED BY MIXiii-BIOMED 07:30 ET | TEL AVIV, Israel, April…
April 2, 2018 | GEN News Highlights AstraZeneca’s #MedImmune subsidiary has agreed to exclusively license and develop #bispecific and multispecific #immuno-oncology antibody products from Compugen’s pipeline, through a collaboration that #Compugen said today…
As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced #clinical trials Lilach Baumer17:4228.03.18 Pharmaceutical company InSight Biopharmaceuticals Ltd. has signed a…
MIXiii-#BIOMED 2018 #Conference chair Ruti Alon: The pendulum has to move back to medical devices, after a decade in which the sector was starved of financing. For almost a…
The ambitious plan is designed to make Israel a digital health power and improve the health of its residents, and of the entire world. Israel's cabinet today approved a NIS…